Overview of The Blood of Dawnwalker
The Blood of Dawnwalker, developed by Rebel Wolves and set for release in 2023, draws inspiration from 14th century Europe, a setting plagued by war and strife. The game features Coen, a half-vampire protagonist navigating this gritty landscape reminiscent of Geralt's journey in The Witcher 3. Game director Konrad Tomaszkiewicz, who directed The Witcher 3, expressed confidence in his new title, stating, "I feel really confident about our game," during an interview with The Game Business.
Tomaszkiewicz has an impressive background in game design, having contributed as a story designer and lead quest designer for The Witcher 3, as well as holding senior roles on Cyberpunk 2077. In 2022, he founded Rebel Wolves to create narrative-driven open-world games that incorporate innovative gameplay mechanics.
Innovative Gameplay Features
The gameplay of The Blood of Dawnwalker promises unique elements that set it apart from typical RPGs. One significant feature is a dynamic day/night cycle, where Coen can only utilize his full range of vampire abilities during nighttime. This mechanic not only enhances gameplay realism but also creates strategic challenges as players navigate quests.
Moreover, the game introduces a sense of time pressure. Unlike Cyberpunk 2077, which allowed players to explore freely despite a looming life-or-death scenario, The Blood of Dawnwalker expects players to engage with its side quests thoughtfully. This design choice means players can't experience all content in a single playthrough, which adds replay value and encourages exploration.
A Vision for the Future
Tomaszkiewicz aims to push the boundaries of AAA RPGs through innovative storytelling and gameplay. He believes that an artistic evolution is necessary, stating, "Opening a new company to do exactly the same things we did in the past is a problem." The team at Rebel Wolves, consisting of around 160 members, hopes to succeed with The Blood of Dawnwalker and subsequently fund two additional games of similar scale.